To ensure our scientific discoveries translate into real-world impact, we actively pursue commercialisation pathways. Through the biotech startup LiverGENIX, we aim to bring our most promising biomarkers, therapeutic targets, and diagnostic tools to market. LiverGENIX serves as a platform to accelerate the development of next-generation solutions for metabolic and liver diseases, bridging innovation from the lab to the clinic.